BioHarvest Sciences Inc (BHST)

BioHarvest Sciences Inc. Common Stock in the Consumer Defensive sector is trading at $1.81 with a market capitalization of $80M. Wall Street consensus targets $10.50 (4 analysts), implying a +480.1% move over the next 12 months. The stock is currently near its 52-week low of $1.80, remaining 55.0% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 23 is oversold, raising the odds of a near-term bounce. The Whystock Score of 50/100 suggests a balanced risk-reward profile.